Ian W. McLeod
Chief Accounting Officer
Anika Therapeutics, Inc. (ANIK)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Ian W. McLeod
Ian W. McLeod is recorded as Chief Accounting Officer at Anika Therapeutics, Inc. (ANIK). The proxy statement of Anika Therapeutics, Inc. reports total compensation of $765,544 for Ian W. McLeod in fiscal 2025, including a base salary of $345,362.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Anika Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Cheryl Blanchard CEO, Board Member
- Stephen (Steve) Griffin CEO, Board Member
- Stephen D. Griffin CEO, CFO, Board Member
- Steve Griffin CEO, Board Member
- Cheryl R. Blanchard Chairman, Board Member
- Jeffery S. Thompson Chairman
- John B. Henneman, III Chairman, Board Member
- Michael Levitz CFO
- Stephen Griffin CFO
- Anne Nunes COO
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Anika Therapeutics, Inc. (ANIK) | SVP, Chief Accounting Officer and Treasurer | $345,362 | $765,544 |
Recent activity
No call appearances or filed executive changes recorded yet.